<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; capital</title>
	<atom:link href="http://www.tapanray.in/tag/capital/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Health, Human Capital, Human Development And GDP Growth – A Discord in India</title>
		<link>http://www.tapanray.in/health-human-capital-human-development-and-gdp-growth-a-discord-in-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=health-human-capital-human-development-and-gdp-growth-a-discord-in-india</link>
		<comments>http://www.tapanray.in/health-human-capital-human-development-and-gdp-growth-a-discord-in-india/#comments</comments>
		<pubDate>Mon, 04 Jul 2016 00:00:36 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[capital]]></category>
		<category><![CDATA[development]]></category>
		<category><![CDATA[discord]]></category>
		<category><![CDATA[economy]]></category>
		<category><![CDATA[GDP. Growth]]></category>
		<category><![CDATA[HCI]]></category>
		<category><![CDATA[HDI]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[human]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7702</guid>
		<description><![CDATA[Is sustainable growth rate of Gross Domestic Product (GDP) intertwined with public health, human capital and human development, or each one of these deserves to be seen and analyzed in isolation? Or, is there a discord between India’s GDP growth rate, &#8230; <a href="http://www.tapanray.in/health-human-capital-human-development-and-gdp-growth-a-discord-in-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/health-human-capital-human-development-and-gdp-growth-a-discord-in-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Takes ‘Two to Tango’: Encashing Opportunities with Biologic drugs in India</title>
		<link>http://www.tapanray.in/takes-two-to-tango-encashing-opportunities-with-biologic-drugs-in-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=takes-two-to-tango-encashing-opportunities-with-biologic-drugs-in-india</link>
		<comments>http://www.tapanray.in/takes-two-to-tango-encashing-opportunities-with-biologic-drugs-in-india/#comments</comments>
		<pubDate>Mon, 11 Feb 2013 00:00:16 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Avesthagen]]></category>
		<category><![CDATA[biologics]]></category>
		<category><![CDATA[biosimilar]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[cadila]]></category>
		<category><![CDATA[capital]]></category>
		<category><![CDATA[DBT]]></category>
		<category><![CDATA[DCGI]]></category>
		<category><![CDATA[DRL]]></category>
		<category><![CDATA[generic]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[IMS]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[large]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[molecule]]></category>
		<category><![CDATA[Orchid]]></category>
		<category><![CDATA[patent-cliff]]></category>
		<category><![CDATA[PPP]]></category>
		<category><![CDATA[PwC]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ranbaxy]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Reliance]]></category>
		<category><![CDATA[SBIRI]]></category>
		<category><![CDATA[Shanta]]></category>
		<category><![CDATA[small]]></category>
		<category><![CDATA[success]]></category>
		<category><![CDATA[tango]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[two]]></category>
		<category><![CDATA[venture]]></category>
		<category><![CDATA[wockhardt]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=1408</guid>
		<description><![CDATA[Despite current ‘Patent Cliff’ ongoing research on biologics is now at the forefront of the Global Pharmaceutical Industry.  The bottom-line impact of a successful new biologic molecule to treat intractable ailments like, cancer, blood disorders, Parkinson&#8217;s, Myasthenia Gravis, Multiple Sclerosis, &#8230; <a href="http://www.tapanray.in/takes-two-to-tango-encashing-opportunities-with-biologic-drugs-in-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/takes-two-to-tango-encashing-opportunities-with-biologic-drugs-in-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
